Literature DB >> 8449698

[The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients].

C C Zouboulis1, P Büttner, D Djawari, W Kirch, W Keitel, C Garbe, H J von Keyserlingk-Eberius, C E Orfanos.   

Abstract

The frequencies of HLA-class I antigens were studied in 39 patients with Adamantiades-Behçet's disease and were compared with those in 1415 [corrected] healthy controls; both patients and controls were of German origin. Moreover, the correlations of HLA antigens with onset, various clinical features and the course of the disease were investigated and the familial clustering of the disease was examined. We found an increased frequency of the HLA-B5 antigen in these series (P < 0.05, relative risk 2.6, confidence interval 1.2-5.5). The presence of HLA-B5 was more frequently detected in male (41%, relative risk 4.9, confidence interval 1.8-13.1) than in female patients (9%; P < 0.05). A significantly higher frequency of HLA-B5 was found in male patients with severe vascular involvement, including blindness and thrombosis, than in HLA-B5-positive male patients without these features. Incidences of genital ulcers, ocular involvement, cutaneous features, positive pathergy test and of secondary symptoms as well as the age of onset and the duration of development of the complete clinical picture were all found not to be significantly correlated with any of the HLA-A, -B, -C alleles. Familial clustering was also not found in German patients. Because of the low relative risk in the presence of HLA-B5 and the lacking familial clustering, it seems likely that there is a weak immunogenetically determined predisposition for Adamantiades-Behçet's disease in Germany. HLA-B5-positive male persons of German origin show a higher relative risk to develop or acquire Adamantiades-Behçet's disease than female ones.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449698

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  5 in total

1.  Primary association of HLA-B51 with Behçet's disease in Ireland.

Authors:  D J Kilmartin; A Finch; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

Review 2.  [Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics].

Authors:  U Pleyer; D Hazirolan; S Winterhalter; N Stübiger
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

3.  [Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?].

Authors:  U Pleyer; D Hazirolan; N Stübiger
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

4.  Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.

Authors:  I Kötter; A K Eckstein; N Stübiger; M Zierhut
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

Review 5.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.